Ralwel/istockphoto.com
Past successes by trailblazers in other biotechnological fields could assist potential patentees navigate legal bumps along the road to IP protection for CRISPR-related inventions, as Patricia Carson and Ashley Ross of Kirkland & Ellis describe.
Renew / upgrade subscription to view the page.
Patricia Carson, Ashley Ross,Kirkland & Ellis, patent, CRISPR, CRISPR/Cas, patents, gene visualisation, UC berkeley, Eukaryotic, US Patent Trial and Appeal
